Subtyping colorectal cancer may improve patient outcome predictions

Colorectal cancer, or CRC, is the world’s second most lethal cancer based on the number of deaths, and is the third most prevalent malignant tumor. Doctors and patients have long been hoping for better diagnostics for prognosis, such as molecular…

Continue Reading

News Source: medicalxpress.com